Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.

Gasparre G, Porcelli AM, Bonora E, Pennisi LF, Toller M, Iommarini L, Ghelli A, Moretti M, Betts CM, Martinelli GN, Ceroni AR, Curcio F, Carelli V, Rugolo M, Tallini G, Romeo G.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):9001-6. Epub 2007 May 15.

3.

Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Mete O, Asa SL.

Endocr Pathol. 2010 Mar;21(1):16-24. doi: 10.1007/s12022-009-9102-2. Review.

PMID:
20013317
4.

Molecular features of thyroid oncocytic tumors.

Gasparre G, Bonora E, Tallini G, Romeo G.

Mol Cell Endocrinol. 2010 May 28;321(1):67-76. doi: 10.1016/j.mce.2010.02.022. Epub 2010 Feb 23. Review.

PMID:
20184940
5.

My approach to oncocytic tumours of the thyroid.

Asa SL.

J Clin Pathol. 2004 Mar;57(3):225-32. Review.

6.

Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors.

Zimmermann FA, Mayr JA, Feichtinger R, Neureiter D, Lechner R, Koegler C, Ratschek M, Rusmir H, Sargsyan K, Sperl W, Kofler B.

Front Biosci (Elite Ed). 2011 Jan 1;3:315-25. Review.

PMID:
21196312
7.

Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands.

Máximo V, Rios E, Sobrinho-Simões M.

Int J Surg Pathol. 2014 Feb;22(1):33-6. doi: 10.1177/1066896913517938. Epub 2014 Jan 9. Review.

PMID:
24406625
8.

Oncocytic lesions of the neuroendocrine system.

Canberk S, LiVolsi VA, Baloch Z.

Adv Anat Pathol. 2014 Mar;21(2):69-82. doi: 10.1097/PAP.0000000000000011. Review.

PMID:
24508690
9.

[Oncocytic metaplasia/neoplasia--morphology, biochemistry, molecular genetics].

Müller-Höcker J.

Pathologe. 1998 Feb;19(2):104-14. Review. German.

PMID:
9556794
10.

Oncocytic and oncocyte-like lesions of the head and neck.

Wakely PE Jr.

Ann Diagn Pathol. 2008 Jun;12(3):222-30. doi: 10.1016/j.anndiagpath.2008.04.007. Review.

PMID:
18486901
11.

Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.

Sobrinho-Simões M, Máximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, Oliveira MC.

Int J Surg Pathol. 2005 Jan;13(1):29-35. Review.

PMID:
15735852
12.

Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.

Máximo V, Sobrinho-Simões M.

Virchows Arch. 2000 Aug;437(2):107-15. Review.

PMID:
10993269
13.

Mitochondrial DNA and human thyroid diseases.

Rogounovitch T, Saenko V, Yamashita S.

Endocr J. 2004 Jun;51(3):265-77. Review.

14.

The biology and the genetics of Hurthle cell tumors of the thyroid.

Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M.

Endocr Relat Cancer. 2012 Jul 18;19(4):R131-47. doi: 10.1530/ERC-11-0354. Print 2012 Aug. Review.

15.

Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers.

De Luise M, Girolimetti G, Okere B, Porcelli AM, Kurelac I, Gasparre G.

Biochim Biophys Acta. 2017 Aug;1858(8):591-601. doi: 10.1016/j.bbabio.2017.01.009. Epub 2017 Jan 20. Review.

PMID:
28115060
16.

Etiopathogenesis of oncocytomas.

Correia M, Pinheiro P, Batista R, Soares P, Sobrinho-Simões M, Máximo V.

Semin Cancer Biol. 2017 Jul 4. pii: S1044-579X(17)30178-5. doi: 10.1016/j.semcancer.2017.06.014. [Epub ahead of print] Review.

PMID:
28687249

Supplemental Content

Support Center